Voloridge Investment Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
VCM
BTW
Voloridge Investment Management's AMPH Position: Q1 2026 in Review
Voloridge Investment Management reduced its Amphastar Pharmaceuticals (AMPH) stake by 26% in Q1 2026, selling an estimated $1.47M and leaving 171,188 shares worth $3.35M. The position accounts for 0.01% of the portfolio, ranked #752.
Voloridge Investment Management first reported a position in AMPH in Q3 2020 and has held it in 18 quarters since. The position peaked at $17.1M in Q3 2023. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.
- Voloridge Investment Management held 171,188 shares of Amphastar Pharmaceuticals worth $3.35M as of Q1 2026.
- Voloridge Investment Management sold 60,117 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $1.47M.
- Amphastar Pharmaceuticals made up 0.01% of Voloridge Investment Management's portfolio in Q1 2026, its #752 holding.
- Voloridge Investment Management first reported a position in Amphastar Pharmaceuticals in Q3 2020 and has held it in 18 quarters since.
- Voloridge Investment Management's Amphastar Pharmaceuticals position peaked at $17.1M in Q3 2023.
- 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.
Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.